Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
11 "Aging"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Article image
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma
Ji Min Na, Dong Chul Kim, Dae Hyun Song, Hyo Jung An, Hyun Min Koh, Jeong-Hee Lee, Jong Sil Lee, Jung Wook Yang, Min Hye Kim
J Pathol Transl Med. 2022;56(4):199-204.   Published online May 11, 2022
DOI: https://doi.org/10.4132/jptm.2022.03.19
  • 3,206 View
  • 172 Download
AbstractAbstract PDF
Background
Myoferlin is a multifunctional protein expressed in various normal and cancer cells, with novel oncogenic roles being newly discovered. Recently, correlations have been found between myoferlin expression and unfavorable prognosis in various carcinomas. This study investigated the prognostic role of myoferlin expression in papillary thyroid carcinoma (PTC), specifically that associated with nodal metastasis.
Methods
We collected clinicopathological data and PTC tissues from 116 patients who had been admitted to Gyeongsang National University Hospital in 2010. Immunohistochemical analysis was performed on surgical specimen-derived tissue microarray blocks. Myoferlin expression was graded, and the relationship between expression level and pathological features of tumors based on the American Joint Committee on Cancer staging system was evaluated.
Results
Of the 116 patient samples, 100 cases exhibited positive myoferlin expression. Higher grade of myoferlin expression was correlated with lower T category group (p = .010). Presence of lymph node metastasis was determined to be significantly correlated with low-grade myoferlin expression (p = .019), with no significant difference between pN1a and pN1b tumors.
Conclusions
Our study revealed an adverse correlation between myoferlin expression and pathological features of PTC, evidence of the potential prognostic role of myoferlin in PTC lymph node metastasis.
Reviews
Article image
Imaging features of breast cancer molecular subtypes: state of the art
Nariya Cho
J Pathol Transl Med. 2021;55(1):16-25.   Published online November 9, 2020
DOI: https://doi.org/10.4132/jptm.2020.09.03
  • 48,841 View
  • 321 Download
  • 15 Web of Science
  • 14 Crossref
AbstractAbstract PDF
Characterization of breast cancer molecular subtypes has been the standard of care for breast cancer management. We aimed to provide a review of imaging features of breast cancer molecular subtypes for the field of precision medicine. We also provide an update on the recent progress in precision medicine for breast cancer, implications for imaging, and recent observations in longitudinal functional imaging with radiomics.

Citations

Citations to this article as recorded by  
  • Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer
    Anupama Praveen Kumar, Diego Vicente, Jianfang Liu, Praveen-Kumar Raj-Kumar, Brenda Deyarmin, Xiaoying Lin, Craig D. Shriver, Hai Hu
    Breast Cancer Research and Treatment.2024; 204(1): 15.     CrossRef
  • The association of magnetic resonance imaging features with five molecular subtypes of breast cancer
    Van Thi Nguyen, Duc Huu Duong, Quang Thai Nguyen, Duy Thai Nguyen, Thi Linh Tran, Tra Giang Duong
    European Journal of Radiology Open.2024; 13: 100585.     CrossRef
  • The effect of data resampling methods in radiomics
    Aydin Demircioğlu
    Scientific Reports.2024;[Epub]     CrossRef
  • Treated Primary Cutaneous Malignant Melanoma With Later Metastasis Found in Clinical Presentation of Left Axilla Lymphadenopathy: A Case Report
    Brigitte L Cochran, Sara Eliseo, Austin Vaughn, Tamryn L Van Der Horn, Enzo Ferrara, Jamie Edwards
    Cureus.2024;[Epub]     CrossRef
  • Pushing the envelope in breast conserving surgery − is multiple-wire localization (3 or more wires) associated with increased risk of compromised margins and long-term recurrence?
    Orit Golan, Marian Khatib, Tehillah S. Menes, Vivianne A.R. Freitas, Rivka Kessner, Rina Neeman, Michal Mauda-Havakuk, Diego Mercer, Yoav Amitai
    European Journal of Radiology.2024; 176: 111511.     CrossRef
  • A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy
    Panagiotis Kapetas, Reena Aggarwal, Basmah Altuwayjiri, Katja Pinker, Paola Clauser, Thomas H. Helbich, Pascal A.T. Baltzer
    European Journal of Radiology.2024; 178: 111649.     CrossRef
  • Correlations of Imaging and Therapy in Breast Cancer Based on Molecular Patterns: An Important Issue in the Diagnosis of Breast Cancer
    Oana Maria Burciu, Ioan Sas, Tudor-Alexandru Popoiu, Adrian-Grigore Merce, Lavinia Moleriu, Ionut Marcel Cobec
    International Journal of Molecular Sciences.2024; 25(15): 8506.     CrossRef
  • Access to prior screening mammograms affects the specificity but not sensitivity of radiologists' performance
    J.D. Akwo, P. D. (Yun) Trieu, M.L. Barron, T. Reynolds, S.J. Lewis
    Clinical Radiology.2024;[Epub]     CrossRef
  • Histogram analysis of multi-model high-resolution diffusion-weighted MRI in breast cancer: correlations with molecular prognostic factors and subtypes
    Yanjin Qin, Feng Wu, Qilan Hu, Litong He, Min Huo, Caili Tang, Jingru Yi, Huiting Zhang, Ting Yin, Tao Ai
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer
    Kai Huang, James W. Jakub, Sarah A. McLaughlin
    Annals of Surgical Oncology.2023; 30(13): 8455.     CrossRef
  • Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights
    Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ammar Ebrahimi
    Molecular Biology Reports.2022; 49(1): 705.     CrossRef
  • MRI as a biomarker for breast cancer diagnosis and prognosis
    Francesca Galati, Veronica Rizzo, Rubina Manuela Trimboli, Endi Kripa, Roberto Maroncelli, Federica Pediconi
    BJR|Open.2022;[Epub]     CrossRef
  • Multiparametric MRI Features of Breast Cancer Molecular Subtypes
    Madalina Szep, Roxana Pintican, Bianca Boca, Andra Perja, Magdalena Duma, Diana Feier, Bogdan Fetica, Dan Eniu, Sorin Marian Dudea, Angelica Chiorean
    Medicina.2022; 58(12): 1716.     CrossRef
  • Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects
    Evagelia Chantzara, Nikolaos Xenidis, Galatea Kallergi, Vassilis Georgoulias, Athanasios Kotsakis
    Expert Review of Molecular Diagnostics.2021; 21(10): 1037.     CrossRef
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations
Jae Hee Cheon
J Pathol Transl Med. 2015;49(3):209-217.   Published online May 15, 2015
DOI: https://doi.org/10.4132/jptm.2015.04.09
  • 12,009 View
  • 95 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Endoscopic assessment has a crucial role in the management of inflammatory bowel disease (IBD). It is particularly useful for the assessment of IBD disease extension, severity, and neoplasia surveillance. Recent advances in endoscopic imaging techniques have been revolutionized over the past decades, progressing from conventional white light endoscopy to novel endoscopic techniques using molecular probes or electronic filter technologies. These new technologies allow for visualization of the mucosa in detail and monitor for inflammation/dysplasia at the cellular or sub-cellular level. These techniques may enable us to alter the IBD surveillance paradigm from four quadrant random biopsy to targeted biopsy and diagnosis. High definition endoscopy and dye-based chromoendoscopy can improve the detection rate of dysplasia and evaluate inflammatory changes with better visualization. Dye-less chromoendoscopy, including narrow band imaging, iScan, and autofluorescence imaging can also enhance surveillance in comparison to white light endoscopy with optical or electronic filter technologies. Moreover, confocal laser endomicroscopy or endocytoscopy have can achieve real-time histology evaluation in vivo and have greater accuracy in comparison with histology. These new technologies could be combined with standard endoscopy or further histologic confirmation in patients with IBD. This review offers an evidence-based overview of new endoscopic techniques in patients with IBD.

Citations

Citations to this article as recorded by  
  • Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
    Yingtong Chen, Xiaoyi Xu, Min Wang, Xiang Wang, Yan Wang, Yong Zhang, Jin Huang, Yuwen Tao, Wentao Fan, Lili Zhao, Li Liu, Zhining Fan
    Photodiagnosis and Photodynamic Therapy.2024; 48: 104220.     CrossRef
  • Colorectal cancer in inflammatory bowel disease: review of the evidence
    D. S. Keller, A. Windsor, R. Cohen, M. Chand
    Techniques in Coloproctology.2019; 23(1): 3.     CrossRef
  • Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
    Jung Won Park, Tae Il Kim, Jae Hee Cheon
    Intestinal Research.2018; 16(4): 641.     CrossRef
  • How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems
    Anna M. Buchner, Gary R. Lichtenstein
    Inflammatory Bowel Diseases.2016; 22(4): 1010.     CrossRef
  • Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
    Anna Chiara Piscaglia, Lucrezia Laterza, Valentina Cesario, Viviana Gerardi, Rosario Landi, Loris Riccardo Lopetuso, Giovanni Calò, Giovanna Fabbretti, Massimo Brisigotti, Maria Loredana Stefanelli, Antonio Gasbarrini
    World Journal of Gastroenterology.2016; 22(46): 10198.     CrossRef
Molecular Imaging in the Era of Personalized Medicine
Kyung-Ho Jung, Kyung-Han Lee
J Pathol Transl Med. 2015;49(1):5-12.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.24
  • 12,076 View
  • 201 Download
  • 30 Web of Science
  • 25 Crossref
AbstractAbstract PDF
Clinical imaging creates visual representations of the body interior for disease assessment. The role of clinical imaging significantly overlaps with that of pathology, and diagnostic workflows largely depend on both fields. The field of clinical imaging is presently undergoing a radical change through the emergence of a new field called molecular imaging. This new technology, which lies at the intersection between imaging and molecular biology, enables noninvasive visualization of biochemical processes at the molecular level within living bodies. Molecular imaging differs from traditional anatomical imaging in that biomarkers known as imaging probes are used to visualize target molecules-of-interest. This ability opens up exciting new possibilities for applications in oncologic, neurological and cardiovascular diseases. Molecular imaging is expected to make major contributions to personalized medicine by allowing earlier diagnosis and predicting treatment response. The technique is also making a huge impact on pharmaceutical development by optimizing preclinical and clinical tests for new drug candidates. This review will describe the basic principles of molecular imaging and will briefly touch on three examples (from an immense list of new techniques) that may contribute to personalized medicine: receptor imaging, angiogenesis imaging, and apoptosis imaging.

Citations

Citations to this article as recorded by  
  • Supramolecular fluorescence biosensing based on macrocycles
    Jia-Hong Tian, Haiqi Xu, Xin-Yue Hu, Dong-Sheng Guo
    Supramolecular Materials.2024; 3: 100063.     CrossRef
  • A non-invasive osteopontin-targeted phase changeable fluorescent nanoprobe for molecular imaging of myocardial fibrosis
    Xueli Zhao, Yuze Qin, Bo Wang, Jiao Liu, Yueyue Wang, Kun Chen, Jia Zhao, Lanlan Zhang, Yuanming Wu, Liwen Liu
    Nanoscale Advances.2024; 6(14): 3590.     CrossRef
  • The Role of Molecular Imaging in Personalized Medicine
    Suliman Salih, Aisyah Elliyanti, Ajnas Alkatheeri, Fatima AlYafei, Bashayer Almarri, Hasina Khan
    Journal of Personalized Medicine.2023; 13(2): 369.     CrossRef
  • Development of a multifunctional platform for near-infrared imaging and targeted radionuclide therapy for tumors
    Huihui He, Ke Li, Hang Li, Shiliang Zhu, Shuai Qin, Yong Mao, Jianguo Lin, Ling Qiu, Chunjing Yu
    European Journal of Pharmaceutics and Biopharmaceutics.2023; 185: 107.     CrossRef
  • Quantum Biotechnology
    Nicolas P. Mauranyapin, Alex Terrasson, Warwick P. Bowen
    Advanced Quantum Technologies.2022;[Epub]     CrossRef
  • Preparation Fe3O4@chitosan-graphene quantum dots nanocomposites for fluorescence and magnetic resonance imaging
    Kai Wang, Xiaoguang Xu, Yan Li, Mayifei Rong, Lifeng Wang, Liying Lu, Jian Wang, Fengwen Zhao, Bowen Sun, Yong Jiang
    Chemical Physics Letters.2021; 783: 139060.     CrossRef
  • Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease
    Teresa Infante, Luca Del Viscovo, Maria Luisa De Rimini, Sergio Padula, Pio Caso, Claudio Napoli
    Journal of Atherosclerosis and Thrombosis.2020; 27(4): 279.     CrossRef
  • Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
    Jonathan M. Pantshwa, Pierre P. D. Kondiah, Yahya E. Choonara, Thashree Marimuthu, Viness Pillay
    Cancers.2020; 12(1): 213.     CrossRef
  • Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
    V. M. Baart, R. D. Houvast, L. F. de Geus-Oei, P. H. A. Quax, P. J. K. Kuppen, A. L. Vahrmeijer, C. F. M. Sier
    EJNMMI Research.2020;[Epub]     CrossRef
  • In vivo SPECT imaging of an 131I-labeled PM 2.5 mimic substitute
    Dong-Hui Pan, Jie Sheng, Xin-Yu Wang, Qian-Huan Huang, Jun-Jie Yan, Li-Zhen Wang, Run-Ling Yang, Dong-Jian Shi, Yu-Ping Xu, Ming-Qing Chen
    Nuclear Science and Techniques.2020;[Epub]     CrossRef
  • Optofluidics in bio-imaging applications
    Sihui Chen, Rui Hao, Yi Zhang, Hui Yang
    Photonics Research.2019; 7(5): 532.     CrossRef
  • Nitrogen-vacancy centers in diamond for nanoscale magnetic resonance imaging applications
    Alberto Boretti, Lorenzo Rosa, Jonathan Blackledge, Stefania Castelletto
    Beilstein Journal of Nanotechnology.2019; 10: 2128.     CrossRef
  • Online molecular image repository and analysis system: A multicenter collaborative open-source infrastructure for molecular imaging research and application
    Mahabubur Rahman, Hiroshi Watabe
    Computers in Biology and Medicine.2018; 96: 233.     CrossRef
  • Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
    Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, Elisabeth Jäckel, David Bauer, Martin Lohse, Alan Wong, Johanna Pufe, Friedrich-Alexander Ludwig, Steffen Fischer, Sandra Hauser, Dieter Greif, M. Teresa Pisabarro, Jens Pietzsch, Markus Pietsch, Reik Lö
    Journal of Medicinal Chemistry.2018; 61(10): 4528.     CrossRef
  • Genomic Interventions in Medicine
    Oluwadurotimi S Aworunse, Oluwatomiwa Adeniji, Olusola L Oyesola, Itunuoluwa Isewon, Jelili Oyelade, Olawole O Obembe
    Bioinformatics and Biology Insights.2018;[Epub]     CrossRef
  • Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI
    Ryan L. Brunsing, Natalie M. Schenker-Ahmed, Nathan S. White, J. Kellogg Parsons, Christopher Kane, Joshua Kuperman, Hauke Bartsch, Andrew Karim Kader, Rebecca Rakow-Penner, Tyler M. Seibert, Daniel Margolis, Steven S. Raman, Carrie R. McDonald, Nikdokht
    Journal of Magnetic Resonance Imaging.2017; 45(2): 323.     CrossRef
  • Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium
    Orazio Schillaci, Nicoletta Urbano
    European Journal of Nuclear Medicine and Molecular Imaging.2017; 44(4): 563.     CrossRef
  • Nano-Magnetic Resonance Imaging (Nano-MRI) Gives Personalized Medicine a New Perspective
    Lorenzo Rosa, Jonathan Blackledge, Albert Boretti
    Biomedicines.2017; 5(1): 7.     CrossRef
  • Optical nanoprobes for biomedical applications: shining a light on upconverting and near-infrared emitting nanoparticles for imaging, thermal sensing, and photodynamic therapy
    E. Hemmer, P. Acosta-Mora, J. Méndez-Ramos, S. Fischer
    Journal of Materials Chemistry B.2017; 5(23): 4365.     CrossRef
  • Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma
    Senthilkumar Kalimuthu, Ju Hye Jeong, Ji Min Oh, Byeong-Cheol Ahn
    International Journal of Molecular Sciences.2017; 18(8): 1639.     CrossRef
  • Chemistry and engineering of cyclodextrins for molecular imaging
    Wing-Fu Lai, Andrey L. Rogach, Wing-Tak Wong
    Chemical Society Reviews.2017; 46(20): 6379.     CrossRef
  • Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T1-MRI
    Jiefang He, Célia S. Bonnet, Svetlana V. Eliseeva, Sara Lacerda, Thomas Chauvin, Pascal Retailleau, Frederic Szeremeta, Bernard Badet, Stéphane Petoud, Éva Tóth, Philippe Durand
    Journal of the American Chemical Society.2016; 138(9): 2913.     CrossRef
  • Nanoparticles in practice for molecular-imaging applications: An overview
    Parasuraman Padmanabhan, Ajay Kumar, Sundramurthy Kumar, Ravi Kumar Chaudhary, Balázs Gulyás
    Acta Biomaterialia.2016; 41: 1.     CrossRef
  • A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain
    Maria I. Falcon, Viktor Jirsa, Ana Solodkin
    Current Opinion in Neurology.2016; 29(4): 429.     CrossRef
  • Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance
    Joonseok Lee, Andrew C. Gordon, Hacksung Kim, Wooram Park, Soojeong Cho, Byeongdu Lee, Andrew C. Larson, Elena A. Rozhkova, Dong-Hyun Kim
    Biomaterials.2016; 109: 69.     CrossRef
Original Articles
Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
Mee-Yon Cho, Jin Hee Sohn, So Young Jin, Hyunki Kim, Eun Sun Jung, Mi-Jung Kim, Kyoung-Mee Kim, Woo Ho Kim, Joon Mee Kim, Yun Kyung Kang, Joon Hyuk Choi, Dae Young Kang, Youn Wha Kim, Eun Hee Choi
Korean J Pathol. 2013;47(3):227-237.   Published online June 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.3.227
  • 13,325 View
  • 142 Download
  • 12 Crossref
AbstractAbstract PDF
Background

There is confusion in the diagnosis and biological behaviors of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), because of independently proposed nomenclatures and classifications. A standardized form of pathology report is required for the proper management of patients.

Methods

We discussed the proper pathological evaluation of GEP-NET at the consensus conference of the subcommittee meeting for the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. We then verified the prognostic significance of pathological parameters from our previous nationwide collection of pathological data from 28 hospitals in Korea to determine the essential data set for a pathology report.

Results

Histological classification, grading (mitosis and/or Ki-67 labeling index), T staging (extent, size), lymph node metastasis, and lymphovascular and perineural invasion were significant prognostic factors and essential for the pathology report of GEP-NET, while immunostaining such as synaptophysin and chromogranin may be optional. Furthermore, the staging system, either that of the 2010 American Joint Cancer Committee (AJCC) or the European Neuroendocrine Tumor Society (ENETS), should be specified, especially for pancreatic neuroendocrine neoplasms.

Conclusions

A standardized pathology report is crucial for the proper management and prediction of prognosis of patients with GEP-NET.

Citations

Citations to this article as recorded by  
  • Analysis of Prognostic Risk Factors of Endoscopic Submucosal Dissection (ESD) and Curative Resection of Gastrointestinal Neuroendocrine Neoplasms
    Yuan Si, ChaoKang Huang, JingBin Yuan, XianHui Zhang, QingQiang He, ZhiJin Lin, Ling He, ZhongXin Liu, Yuvaraja Teekaraman
    Contrast Media & Molecular Imaging.2022;[Epub]     CrossRef
  • Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms
    Dong-Wook Kang, Baek-hui Kim, Joon Mee Kim, Jihun Kim, Hee Jin Chang, Mee Soo Chang, Jin-Hee Sohn, Mee-Yon Cho, So-Young Jin, Hee Kyung Chang, Hye Seung Han, Jung Yeon Kim, Hee Sung Kim, Do Youn Park, Ha Young Park, So Jeong Lee, Wonae Lee, Hye Seung Lee,
    Journal of Pathology and Translational Medicine.2021; 55(4): 247.     CrossRef
  • Preoperative diagnosis of well‐differentiated neuroendocrine tumor in common hepatic duct by brush cytology: A case report
    Jiwoon Choi, Kyong Joo Lee, Sung Hoon Kim, Mee‐Yon Cho
    Diagnostic Cytopathology.2019; 47(7): 720.     CrossRef
  • Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
    Bohyun Kim, Han-Seong Kim, Kyung Chul Moon
    Diagnostic Pathology.2019;[Epub]     CrossRef
  • Primary low‐grade neuroendocrine carcinoma of the skin: An exceedingly rare entity
    Tiffany Y. Chen, Annie O. Morrison, Joe Susa, Clay J. Cockerell
    Journal of Cutaneous Pathology.2017; 44(11): 978.     CrossRef
  • Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors
    Jae Hee Cho, Ji Kon Ryu, Si Young Song, Jin-Hyeok Hwang, Dong Ki Lee, Sang Myung Woo, Young-Eun Joo, Seok Jeong, Seung-Ok Lee, Byung Kyu Park, Young Koog Cheon, Jimin Han, Tae Nyeun Kim, Jun Kyu Lee, Sung-Hoon Moon, Hyunjin Kim, Eun Taek Park, Jae Chul Hw
    Pancreas.2016; 45(7): 941.     CrossRef
  • Early diagnosis and treatment of gastrointestinal neuroendocrine tumors
    Hong Shen, Zhuo Yu, Jing Zhao, Xiu-Zhen Li, Wen-Sheng Pan
    Oncology Letters.2016; 12(5): 3385.     CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
  • Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade
    Koji Takumi, Yoshihiko Fukukura, Michiyo Higashi, Junnichi Ideue, Tomokazu Umanodan, Hiroto Hakamada, Ichiro Kanetsuki, Takashi Yoshiura
    European Journal of Radiology.2015; 84(8): 1436.     CrossRef
  • Tumeurs neuroendocrines du tube digestif et du pancréas : ce que le pathologiste doit savoir et doit faire en 2014
    Jean-Yves Scoazec, Anne Couvelard
    Annales de Pathologie.2014; 34(1): 40.     CrossRef
  • Spectrum of Gastroenteropancreatic NENs in Routine Histological Examinations of Bioptic and Surgical Specimen: A Study of 161 Cases Collected from 17 Departments of Pathology in the Czech Republic
    Václav Mandys, Tomáš Jirásek
    Gastroenterology Research and Practice.2014; 2014: 1.     CrossRef
  • p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors
    Hee Sung Kim, Hye Seung Lee, Kyung Han Nam, Jiwoon Choi, Woo Ho Kim
    Cancer Research and Treatment.2014; 46(4): 383.     CrossRef
The Definition of Minimal Extrathyroid Extension in Thyroid Pathology by Analyzing Sizable Intra- and Extrathyroid Blood Vessels
Hyae Min Jeon, Beom Jin Lim, Hang-Seok Chang, SoonWon Hong
Korean J Pathol. 2012;46(6):548-553.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.548
  • 8,821 View
  • 44 Download
  • 7 Crossref
AbstractAbstract PDF
Background

To define the exact boundary of the intrathyroid and extrathyroid aspects of a gland when determining the extent of cancer invasion, we plan to clarify the definition of sizable vascular structures, which is one of the helpful histologic clues in determining a minimal extrathyroid extension. We hypothesized that arterial wall thicknesses in extrathyroid soft tissue would be significantly different from the arteries in the thyroid parenchyma.

Methods

Twenty cases of papillary carcinoma were selected. The numbers and wall thicknesses of the arteries and arterioles in intrathyroid and extrathyroid tissue were evaluated. The absence of nerve tissue in the thyroid gland was confirmed using the S-100 protein immunohistochemical stain.

Results

The comparison of the mean thicknesses of the total arteries between the extrathyroid and intrathyroid tissues in the retrospective study (26.88 µm vs. 15.07 µm, respectively) and the prospective study (35.24 µm vs. 16.52 µm, respectively) revealed significant differences (p=0.000). The greatest thickness of the intrathyroid arteries was 67.93 µm.

Conclusions

According to our results, the study showed that the extrathyroidal arteries were significantly thicker than the intrathyroidal arteries. We suggest that the sizable blood vessels of extrathyroidal arteries should be greater than 67.93 µm in thickness.

Citations

Citations to this article as recorded by  
  • Invasion in thyroid cancer: Controversies and best practices
    Michiya Nishino, Jack Jacob
    Seminars in Diagnostic Pathology.2020; 37(5): 219.     CrossRef
  • MiR-221/222 promote migration and invasion, and inhibit autophagy and apoptosis by modulating ATG10 in aggressive papillary thyroid carcinoma
    Hao Shen, Zaikai Lin, Haiyan Shi, Lingling Wu, Baojin Ma, Hong Li, Baobing Yin, Jun Tang, Hongjin Yu, Xiaoxing Yin
    3 Biotech.2020;[Epub]     CrossRef
  • Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
    Zeming Liu, Yihui Huang, Sichao Chen, Di Hu, Min Wang, Ling Zhou, Wei Zhou, Danyang Chen, Haifeng Feng, Wei Wei, Chao Zhang, Wen Zeng, Liang Guo, Scott M. Langevin
    PLOS ONE.2019; 14(6): e0218171.     CrossRef
  • miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma
    Chengbiao Liu, Meiling Xing, Liping Wang, Kejun Zhang
    British Journal of Biomedical Science.2017; 74(2): 90.     CrossRef
  • Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas
    Chang Gok Woo, Chang Ohk Sung, Yun Mi Choi, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Suck Joon Hong, Dong Eun Song
    Annals of Surgical Oncology.2015; 22(S3): 728.     CrossRef
  • Intraoperative Frozen Section for the Evaluation of Extrathyroidal Extension in Papillary Thyroid Cancer
    Om Prakash Prajapati, A. K. Verma, M. Sabaretnam
    World Journal of Surgery.2015; 39(7): 1855.     CrossRef
  • Tumor Sprouting in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Recurrence
    Eunjung Lee, Wonkyung Jung, Jeong-Soo Woo, Jae Bok Lee, Bong Kyung Shin, Han Kyeom Kim, Aeree Kim, Baek-hui Kim
    Korean Journal of Pathology.2014; 48(2): 117.     CrossRef
Short Case Report
Pineal Parenchymal Tumor of Intermediate Differentiation with Gangliocytic Differentiation: A Case Report.
Lee So Maeng
Korean J Pathol. 2009;43(4):364-367.
DOI: https://doi.org/10.4132/KoreanJPathol.2009.43.4.364
  • 2,961 View
  • 27 Download
  • 1 Crossref
AbstractAbstract PDF
A 49-year-old man presented with an extremely rare case of pineal parenchymal tumor with gangliocytic cells, manifesting as progressive gait disturbance and urinary incontinence lasting for one year. Brain MRI revealed a homogenously enhancing mass, measuring 3.5x2.7 x1.7 cm, in the pineal body. The mass compressed the deep cerebral vein with superior displacement, which caused mild obstructive hydrocephalus. Histological examination revealed lobular structures consisting of isomorphic small round cells with stippled chromatin and clear cytoplasm, and less cellular areas having large pleomorphic cells and ganglioid cells. Mitotic figures and tumor necrosis were not evident. Immunohistochemically, the neoplastic cells were positive for neuronal markers (neuron-specific enolase, neurofilament, NeuN and synaptophysin), but not for glial fibrillary acidic protein or S-100. Especially, neurofilament showed diffuse interstitial immunoreactivity with accentuation in a few gangliocytic cells and Ki-67 labeling index (2.5%) was low. Therefore, this case was diagnosed as pineal parenchymal tumor of intermediate differentiation with gangliocytic differentiation.

Citations

Citations to this article as recorded by  
  • Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades
    Hajime Takase, Reo Tanoshima, Navneet Singla, Yoshihiko Nakamura, Tetsuya Yamamoto
    Neurosurgical Review.2022; 45(2): 1135.     CrossRef
Original Articles
A Standardized Pathology Report for Colorectal Cancer.
Hee Jin Chang, Cheol Keun Park, Woo Ho Kim, Young Bae Kim, Youn Wha Kim, Ho Guen Kim, Han Ik Bae, Kyu Sang Song, Mee Soo Chang, Hee Kyung Chang, Yang Seok Chae
Korean J Pathol. 2006;40(3):193-203.
  • 2,329 View
  • 142 Download
AbstractAbstract PDF
BACKGROUND
AND METHODS: For standardizing the pathology report and diagnosis of colorectal cancers, the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists has developed a pathology reporting format for colorectal cancer in collaboration with the Korean Society of Coloproctology.
RESULTS
The diagnostic parameters are divided into two parts: the standard part and the optional part. The standard part contains most of the items listed in the Japanese classification, the TNM classification by AJCC, and the WHO classification. We included detailed descriptions on each item.
CONCLUSIONS
The standardized pathology report for colorectal cancers is adequate for its application to routine surgical pathology reports, and it is also helpful to decrease the discrepancies that occur during the pathologic diagnosis of colorectal cancer. Furthermore, this reporting format could encourage nationwide multi-center collaborative studies.
A Standardized Pathology Report for Gastric Cancer.
Woo Ho Kim, Cheol Keun Park, Young Bae Kim, Youn Wha Kim, Ho Guen Kim, Han Ik Bae, Kyu Sang Song, Hee Kyung Chang, Hee Jin Chang, Yang Seok Chae
Korean J Pathol. 2005;39(2):106-113.
  • 4,009 View
  • 326 Download
AbstractAbstract PDF
BACKGROUND
AND METHODS: The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists developed a standardized pathology reporting format for gastric cancer in collaboration with the Korean Gastric Cancer Association. RESULTS: The diagnostic parameters are divided into two part: the standard part and the optional part. The standard part contains most of the items listed in the Japanese classification, the TNM classification by UICC, the WHO classification, and the Korean Gastric Cancer Association classification. Therefore, the standard part is adequate for routine surgical pathology service. We included detailed descriptions on each item.
CONCLUSIONS
The authors anticipate that this standardization can improve the diagnostic accuracy and decrease the discrepancies that occur in the pathologic diagnosis of gastric cancer. Furthermore, the standard format can encourage large scale multi-institutional collaborative studies.
Nitric Oxide Synthase Expression in Early Stage of Aging Rat Kidney.
Kye Won Kwon, Hyeon Joo Jeong
Korean J Pathol. 2004;38(2):86-92.
  • 1,639 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Nitric oxide synthase (NOS) has been suggested to have a role in renal injury of aging rats.
METHODS
Renal function and histology were compared between 12 month-and 7-9 week-old rats. Proliferating activity and cell death were evaluated by PCNA index and apoptosis. Three isoforms of NOS (eNOS, iNOS, and nNOS) were stained by immunohistochemistry.
RESULTS
Serum creatinine level was increased in old rats (1.0 mg/dL vs 0.5 mg/dL, p=0.000). 24 h proteinuria and urinary NO were comparable between the two groups. The percentage of global and segmental glomerulosclerosis increased in old rats. PCNA index decreased in the glomeruli (0.1 vs 0.6/glomerulus, p=0.005) and the tubulointerstitium (10.2 vs 19.2/mm2, p=0.019) of old rats compared to that of young rats. However, no difference was observed in the number of TUNEL positive cells. eNOS was not stained in young and old rat kidney, whereas iNOS was stained in the interstitial inflammatory cells of old rats (0.3 vs 0.0 of young rats/mm2, p=0.188). Macula densa nNOS staining significantly decreased in old rats compared to young rats (5.6 vs 9.5/mm2, p=0.009).
CONCLUSIONS
Proliferating activity is more affected than cell death with aging. Decreased nNOS expression without alteration of eNOS and iNOS expressions may implicate nNOS as a marker of renal injury in the early stage of aging.
Nevus Sebaceous with Special Reference on Its Aging Effect.
Jin Seok Seo, Mi Kyung Kim, Mikyung Kim, Kye Yong Song, Yun Lim Seo, Je G Chi
Korean J Pathol. 1990;24(4):436-445.
  • 1,626 View
  • 26 Download
AbstractAbstract PDF
A histopathological study was performed on nevus sebaceus to observe its aging effect based on 75 cases of neuvs sebaceus those were collected during the past 10 years from three university hospitals in Seoul. The results are as follows: 1) Clinical findings The incidence was most frequent in the teenage group. The 75 cases consisted of 41 males and 34 females with a sex ratio of 1.2:1. Most of cases developed in the head and neck areas with 62.7% on the scalp and 29.3% on the face. 2) Histopathologic findings. The epidermal changes such as acanthosis(40%), papillomatosis(73%), hypergranulosis(44%) were most remarkable in the second decade and gradually decreased with aging. The apparent proliferation of sebaceous gland was observed in 73% and it was most prominent in the second decade. Apocrine glands were absent before the first decade but apparently increased after then. Proliferation of eccrine gland was not significant in all the age groups. Mild increase of immature hair follicles were noted in 49% of our cases with gradually decreasing tendency in the older age. The dermal inflammatory infiltrates were noted from the 2nd decade(28%) and thereafter gradually increased. Associated neoplasms were one apocrine adenoma, one sebaceous adenoma, two trichilemmomas and two arteriovenous hemangiomas. The majority of tumors occured in the third decade. Therefore, it is observed that neuvs sebaceous undergoes dynamic histopathologic changes according to the age of patient and later develop various secondary neoplastic changes. The pathogenesis of the nevus sebaceus is suggested to be closely related with developmental anomalies of primitive hair germ units in fetal stage.

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP